Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 134, Issue 5, Pages 1024-1033Publisher
WILEY
DOI: 10.1002/ijc.28246
Keywords
receptor tyrosine kinases; cancer; Axl; cancer therapy; drug resistance
Categories
Funding
- International Centre for Genetic Engineering and Biotechnology
Ask authors/readers for more resources
The receptor tyrosine kinase Axl has been implicated in the malignancy of different types of cancer. Emerging evidence of Axl upregulation in numerous cancers, as well as reports demonstrating that its inhibition blocks tumor formation in animal models, highlight the importance of Axl as a new potential therapeutic target. Furthermore, recent data demonstrate that Axl plays a pivotal role in resistance to chemotherapeutic regimens. In this review we discuss the functions of Axl and its regulation and role in cancer development, resistance to therapy, and its importance as a potential drug target, focusing on acute myeloid leukemia, breast, prostate and non-small cell lung cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available